REE:NASDAQREE Automotive Ltd. Analysis
Data as of 2026-07-16 - not real-time
$0.08
Latest Price
9/10Risk
Risk Level: High
Executive Summary
REE Automotive is trading at $0.0769, barely above its 30‑day support of $0.067 and far below its 20‑day SMA of 0.188, 50‑day SMA of 0.329 and 200‑day SMA of 0.636, confirming a strong bearish price structure. The RSI 14 sits at 15.4, indicating extreme oversold conditions, while the MACD line remains under the signal line with a negative histogram, reinforcing the bearish momentum. Volume has been increasing, yet the stock exhibits a staggering 310% 30‑day volatility and a historic max drawdown of ‑94.5%, underscoring extreme price instability. Compounding the technical weakness, Nasdaq has issued a delisting notice for failure to meet Listing Rule 5550(a)(2), placing the share’s continued market presence in jeopardy.
Fundamentally, REE reports only $1.30 M in revenue despite a 45% growth rate, but its gross margin is a negative ‑26% and operating margin a negative ‑8.7%, with no earnings and a cash burn of $68.7 M. The balance sheet shows $19.2 M of debt versus $14.2 M of cash, yielding a debt‑to‑equity ratio above 283, and both ROE and ROA are deeply negative. Valuation multiples are low (P/B < 0.33, P/S ~1.73) but are outweighed by the company’s financial distress, lack of dividend, and regulatory risk, making the stock a high‑risk speculative play.
Fundamentally, REE reports only $1.30 M in revenue despite a 45% growth rate, but its gross margin is a negative ‑26% and operating margin a negative ‑8.7%, with no earnings and a cash burn of $68.7 M. The balance sheet shows $19.2 M of debt versus $14.2 M of cash, yielding a debt‑to‑equity ratio above 283, and both ROE and ROA are deeply negative. Valuation multiples are low (P/B < 0.33, P/S ~1.73) but are outweighed by the company’s financial distress, lack of dividend, and regulatory risk, making the stock a high‑risk speculative play.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Nasdaq delisting notice
- Bearish technicals (price below all SMAs, RSI 15)
- Negative earnings and cash flow
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued operating losses
- High debt load relative to equity
- Elevated volatility and drawdown risk
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Unclear path to profitability
- Potential delisting and loss of market access
- Sector cyclicality without a clear competitive moat
Key Metrics & Analysis
Financial Health
Revenue Growth4537.50%
P/E Ratio-0.0
ROE-373.57%
ROA-47.23%
Debt/Equity283.87
P/B Ratio0.3
Op. Cash Flow$-68710000
Free Cash Flow$-32616000
Technical Analysis
TrendBearish
RSI15.4
Support$0.07
Resistance$0.57
MA 20$0.19
MA 50$0.33
MA 200$0.64
MACDBearish
VolumeIncreasing
Fear & Greed Index92.7
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.67
Volatility310.68%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.